These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2150125)
41. [What value does the stent have for the vascular surgeon]. Menges HW; Prokein E Vasa Suppl; 1992; 35():178-80. PubMed ID: 1481037 [No Abstract] [Full Text] [Related]
42. [Rotational angioplasty for occlusion passage before balloon dilatation or atherectomy]. Osterhues HH; Vogelpohl M; Felder C; Kochs M; Hombach V Vasa Suppl; 1991; 32():122-8. PubMed ID: 1837619 [No Abstract] [Full Text] [Related]
43. [Prospective study of the recanalization of arterial occlusions with a newly developed guide wire/catheter combination]. Wagner HJ; Stephan S; Starck E; Truss J Vasa Suppl; 1991; 33():196. PubMed ID: 1838634 [No Abstract] [Full Text] [Related]
45. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution]. Weidinger P; Bilek M; Tekusch A Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564 [No Abstract] [Full Text] [Related]
46. [Percutaneous infragenual angioplasty--5 years result of 151 cases]. Hold M; Mendel H; Raynoschek H; Schlegl A; Hagmüller G Vasa Suppl; 1992; 37():54-6. PubMed ID: 1481101 [No Abstract] [Full Text] [Related]
47. [Long-term follow-up of patients with peripheral arterial occlusive disease after balloon dilatation in the femoropopliteal area]. Lafer M; Decrinis M; Pilger E; Stark G; Obernosterer A; Tischler R; Doder A; Klein EG; Hausegger H Vasa Suppl; 1992; 37():52-3. PubMed ID: 1481100 [No Abstract] [Full Text] [Related]
48. [Comparison of 50 mg and 900 mg/day acetylsalicylic acid for prevention of recurrence after percutaneous transluminal angioplasty of the lower extremities: results of the LARA study]. Ranke C; Creutzig A; Luska G; Wagner HH; Galanski M; Frölich JC; Avenarius HJ; Hecker H; Alexander K Vasa Suppl; 1992; 35():42-5. PubMed ID: 1481057 [No Abstract] [Full Text] [Related]
49. [Results of conservative treatment in patients with atheromatous obstruction of arteries in the leg]. Grochowiecki T; Nawrot I; Porzycki P; Tołłoczko T Pol Tyg Lek; 1992 May 4-11; 47(18-19):416-7. PubMed ID: 1409056 [TBL] [Abstract][Full Text] [Related]
50. [Assessment of thrombocyte deposits and thrombocyte survival following catheter dilatation of the lower extremities using 111-indium marked thrombocytes]. Marosi L; Minar E; Ahmadi R; Cechota C; Koppensteiner R; Jung M; Schöfl R Vasa Suppl; 1988; 23():186-8. PubMed ID: 2974637 [No Abstract] [Full Text] [Related]
51. [Arterial occlusive disease: thrombolysis]. Martin M; Fiebach BJ Verh Dtsch Ges Inn Med; 1990; 96():371-4. PubMed ID: 2092455 [No Abstract] [Full Text] [Related]
53. [Simpson atherectomy--long-term results and indications]. Lugmayr H; Deutsch M; Pachinger O Vasa Suppl; 1991; 33():44-6. PubMed ID: 1838643 [No Abstract] [Full Text] [Related]
54. [Arterial interventional measures using carbon dioxide (CO2) as a contrast medium]. Strunk H; Schild H; Mortasawi MA Rofo; 1992 Dec; 157(6):599-600. PubMed ID: 1457799 [No Abstract] [Full Text] [Related]
55. Protective effect of smoking: misleading use of statistics. Corrao S Radiology; 2004 Dec; 233(3):934; author reply 934. PubMed ID: 15564413 [No Abstract] [Full Text] [Related]
56. Catheter lysis in advanced peripheral OAD--procedure of choice or last resort? Stein U; Amendt K; Wagner E; Hild R Vasa; 1987; 16(4):358-61. PubMed ID: 2962384 [No Abstract] [Full Text] [Related]
57. [The effect of training by walking in relation to age and comorbidity using the Essen model]. Bunse C; Klemp U; Bisler H Vasa Suppl; 1992; 35():67-8. PubMed ID: 1481065 [No Abstract] [Full Text] [Related]